Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty(Ⓡ)]).
Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty(Ⓡ)]).
复制标题
DOI:
10.1016/j.ijid.2022.09.019
复制
发表时间:
2022-11
影响因子:
8.4
通讯作者:
Hiramatsu, Kazufumi
中科院分区:
文献类型:
--
作者:
Ando, Masaru;Satonaga, Yoshio;Takaki, Ryuichiro;Yabe, Michitoshi;Kan, Takamasa;Omote, Erika;Yamasaki, Toru;Komiya, Kosaku;Hiramatsu, Kazufumi
The messenger RNA vaccine against SARS-CoV-2 is effective at preventing COVID-19-associated hospitalization, and the Centers for Disease Control and Prevention has recommended vaccination for all eligible individuals. We demonstrate a case involving a patient who developed a life-threatening acute asthma exacerbation after receiving their third dose of the BNT16b2 vaccine. Because eosinophilia was observed after the second inoculation, it was considered likely that the patient had been sensitized to the BNT16b2 vaccine. Theoretically, the SARS-CoV-2 vaccine could trigger the exacerbation of asthma. It should be recognized that repeated SARS-CoV-2 vaccination may be a risk factor for the acute exacerbation of asthma.
登录
查看更多内容
DOI:
10.1056/nejmoa2110345
发表时间:
2021-11-04
期刊:
The New England journal of medicine
影响因子:
--
作者:
Thomas SJ;Moreira ED Jr;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Polack FP;Zerbini C;Bailey R;Swanson KA;Xu X;Roychoudhury S;Koury K;Bouguermouh S;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Yang Q;Liberator P;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Gruber WC;Jansen KU;C4591001 Clinical Trial Group
通讯作者:
C4591001 Clinical Trial Group
DOI:
10.1111/j.1365-2222.1985.tb02290.x
发表时间:
1985-01-01
期刊:
CLINICAL ALLERGY
影响因子:
--
作者:
DURHAM, SR;KAY, AB
通讯作者:
KAY, AB
影响因子:
3.1
作者:
Korekawa, Ayumi;Nakajima, Koji;Sawamura, Daisuke
通讯作者:
Sawamura, Daisuke
DOI:
10.7759/cureus.21176
发表时间:
2022-01
期刊:
Cureus
影响因子:
--
作者:
Ibrahim H;Alkhatib A;Meysami A
通讯作者:
Meysami A
影响因子:
2.9
作者:
Uzer F;Cilli A
通讯作者:
Cilli A